DEM Annual Conference
Call for Oral and Poster Abstracts

Deadline for submission of abstracts is
Friday, July 13, 2018 at 11:00pm PDT.

Free registration will be offered to those selected to present in the plenary oral abstract session. There will also be prizes for the best poster abstracts in each category, as well as the overall best oral abstract.

Please review the abstract guidelines and CME compliance requirements at the bottom of this page. Then choose the category that best matches your project and click "Begin a Submission" to get started.


Abstract Submission Deadline 11pm PDT: 2018-07-13

Deadline Passed

Scientific Abstracts should report the results of original research related to diagnostic error in medicine and must contain quantitative or qualitative data. Each abstract should be 400 words or less, have a descriptive title, and the following 4 sections:





This may include 1 table or figure.

Abstract Submission Deadline 11pm PDT: 2018-07-13

Deadline Passed

Practice Improvement Abstracts should describe programs, strategies, tools, or solutions to improve communication or information flow, and/or process performance for clinical providers and patients to reduce harm associated with diagnostic error in diverse delivery systems. Ideally, these should be solutions that can be quickly implemented in routine practice. Programs addressing diagnostic error in medicine that have been piloted or implemented are encouraged. These abstracts should include information that allows session attendees to evaluate the replicability of such programs at their institutions. This category is intended for descriptive abstracts as well as programs with more rigorous evaluations. Solutions may be related to but not limited to practice management, patient engagement, and/or use of health information technology. Each abstract should be 400 words or less, have a descriptive title, and the following 4 sections:

Statement of problem:

Description of the intervention or program:

Findings to date:

Lessons learned:

This may include 1 table or figure.

Abstract Submission Deadline 11pm PDT: 2018-07-13

Deadline Passed

Education Abstracts should describe educational programs, evaluation of educational programs, learner assessments, or other aspects of improving diagnosis through health professions education. Studies formally addressing pedagogy, assessment, and development of expertise are also invited. While all submissions are welcomed, we especially encourage descriptions of programs that have robust assessment and evaluation methodology. Further, submissions should address challenges to generalizability of the work as well as integration into existing educational structures. Abstracts should be 400 words or less, have a descriptive title, and follow the outline below:


Description of program, assessment, or study:



Significance of findings:

This may include 1 table or figure.

Abstract Submission Deadline 11pm PDT: 2018-07-13

Deadline Passed

Clinical Vignettes should be cases or scenarios that highlight actual or potential diagnostic errors and have educational value for a wider audience. They should also include a brief discussion of the relevant scientific literature. Each vignette should be 300 words or less, have a descriptive title, and the following 3 sections:

Learning objectives:

Case information:


This may include 1 table or figure.


  • The abstract title should be brief and clear. Abbreviations must not be used in abstract titles.
  • Please state authors' names and institutional affiliations in separate fields. If an author does NOT have an institutional affiliation, indicate their city, state/province, and country; omit titles, degrees, institutional appointments, street names, and postal codes.
  • Single space all typing with one space between paragraphs.
  • Underlining or capitalization for emphasis is not permitted.
  • Simple tables or graphs may be included, but will contribute 50 words towards the word limit. Please note that images may be reduced in size during online submission and only these scaled down images will be visible to reviewers and printed in the conference program booklet or other media. Please consider rewriting the abstract with fewer words if you wish to have a large sized image visible to reviewers and displayed in the conference program booklet.
  • Graphs can be uploaded in color, however, please note that all images will be printed in black and white in the conference program booklet and other print publications. We recommend creating images in black and white for uploading.
  • All abstracts should report original work. If submitting work that has been presented or published elsewhere, please indicate this clearly in your submission. Because of copyright law, a submitted abstract may not be identical to a previously published abstract. There is no limit on the total number of abstracts submitted by each presenter. However, if one author submits more than one abstract about the same data set, the abstracts should be substantially different. Furthermore, each presenter is limited to a maximum of 2 oral presentations and any additional accepted abstracts (beyond the 2 oral presentations) will be slotted for poster presentation. There is no limit to the number of poster presentations per individual.
  • All accepted presenters will be required to register for the conference. Trainees (students, residents, fellows and post-docs) who have a clinical vignette selected for the Diagnostic Error and Clinical Reasoning Case Presentations or an abstract selected for plenary oral abstracts presentations will be offered free registration.
  • Authors have to approve of publication of their accepted abstracts in the open access journal Diagnosis (
  • Except as noted above, presenters are responsible for all travel/staying expenses associated with oral or poster presentation.



All educational materials used in live programs and enduring formats must adhere to the following requirements:

  • For oral presenters, please include a slide at the beginning of your presentation stating your learning objective(s).
  • For poster presenters, please include a learning objective(s), in easily readable font, on the poster.
  • Educational materials that are part of a CME activity cannot contain any advertising, trade name, or product-group message.
  • Use of product brand names is not permitted.
  • Use of trademarks or registered service marks for any organization without their permission (except for clinical citations) will not be permitted.
  • Use of company slides is not permitted.
  • Objectivity and fair balance means that recommendations or emphasis must fairly represent, and be based on, a reasonable and valid interpretation of the information available on the subject (e.g., "On balance the data support the following ..."). A balanced view of therapeutic options also means that no single product or service is over-represented in the educational activity when other equal but competing products or services are available for inclusion.
  • For slide presentations and print materials, each slide or key teaching point must state the kind of trial that demonstrates the data being discussed. Slides are not required to state, for example, "Level 1 evidence" (although it is acceptable to include it), but slides are required to include a statement, for example, "Systematic review of 35 RCTs..." or "Case-controlled trial..." that supports what is being discussed and presented within each slide. This is a conventional approach in the tradition of evidence-based medicine and may be viewed at the Oxford Centre for Evidence-Based Medicine.


  • All presenters are required to disclose any (potential) conflicts of interest.
  • For oral presenters, please include a slide at the beginning of your presentation stating potential conflicts of interest or stating "No Conflicts".
  • For poster presenters, please include a statement at the bottom of your poster, in easily readable font, stating potential conflicts of interest or stating "No Conflicts".
  • Presenters must promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

All submitters will be notified of their acceptance status by the end of August 2018.